CAR-T Cell Therapy Package

CAR-T (Chimeric Antigen Receptor T-cell) therapy is a next-generation immunotherapy in which a patient's own T-cells are collected, genetically re-engineered in the laboratory to recognise and destroy cancer cells, then infused back into the body. The approach is being applied at leading cancer centres in China and India, primarily for leukaemia, lymphoma and multiple myeloma. This package covers: initial medical file review, connection to a CAR-T-experienced centre, visa and travel assistance, and post-treatment follow-up coordination. Content is for reference only; eligibility is determined by the treating physician.